Attention Deficit/Hyperactivity Disorder Sample Clauses

Attention Deficit/Hyperactivity Disorder. The diagnosis of and treatment for Attention Deficit/Hyperactivity Disorder is covered when rendered or prescribed by a Physician or Allied Health Professional. However, Benefits provided will not exceed two thousand five hundred dollars ($2,500.00) per Benefit Period. You will be responsible for charges in excess of the Benefit Period maximum, if any. Charges in excess of the Benefit Period maximum are non-Covered Services and do not accrue to Your Out-of-Pocket Amount.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Attention Deficit/Hyperactivity Disorder. Knowledge and Skills: Training Program for Educators. Bingley: Council for Exceptional Children. Emerald Group Publishing Limited, Bingley Xxxxxxxx, X. X., Xxxxxxxxx, X., Xxxxxx, X., & Xxxxxxx, S. (1994). Teacher preferences for collaborative relationships: relationship to efficacy for teaching in prevention‐related domains. Psychology in the Schools, 31(3), 221-231. Xxxxxxx, X. X., Xxxxxx, X., Xxxxxx, P. C., & Xxxxxxx, N. (2010). Teacher learning and collaboration in innovative teams. Cambridge Journal of Education, 40(2), 161-181 Xxxxxx, X., & Xxxxxxx, X. X. (2006). Technological pedagogical content knowledge: A framework for teacher knowledge. Teachers college record, 108(6), 1017-1054. Ministry of Education and Science (2016). State Programme for Education and Science Development 2016-2019. Retrieved from: xxxx://xxx.xxxxxxxxxx.xx/en Xxxxxxxx, X. X. (2012). 10 tips for using co-planning time more efficiently. Teaching Exceptional Children, 44(4), 8-15. Xxxx, X. X., Xxx, X., & Xxx, X. X. (2015). Relationships between teacher value orientations, collegiality, and collaboration in school professional learning communities. Social Psychology of Education, 18(2), 337-354. X'Xxxxx, X. X., & Xxxxxxxx, X. X. (2013). Quantitative research for the qualitative researcher. California: SAGE publications. Xxxxxxxx, X. (1994). NCREL monograph: Building collaborative cultures: Seeking ways to reshape urban schools. NCREL’s Urban Education Monograph Series. Xxxxx-Xxxx, X. (2007). Teacher support systems: A collaboration model. Principal Leadership, 7(9), 38–41. Xxxxxx, X. X. (2002). Two decades of developments in qualitative inquiry: A personal, experiential perspective. Qualitative Social Work, 1(3), 261-283. Xxxxxx, X., & Xxxxxxxx, X. (2002). Coaching, mentoring and peer-networking: Challenges for the management of teacher professional development in schools. Journal of In-Service Education, 28(2), 297-310. Xxxxxxx, X., XxXxxxxxx, X., & Xxxxxx, A. K. (2001). Xxxxxxxxx and collaboration in teacher education reform. Canadian Journal of Education/ Vol. 26, No. 1 (2001 Revue canadienne de l'education, 37-55. Xxxxxxx, X. X. (2014). Collaborative planning and teacher efficacy of high school mathematics co-teachers. Educational Planning, 21(3), 41-53. Xxxxxxxx, X., Xxxxxx, S. O., XxXxxxx, X., & Xxxxxxx, X. X. (2015). Teacher collaboration in instructional teams and student achievement. American Educational Research Journal, 52(3), 475-514. Xxxxx, X., Xxxxx, X., XxXxxxx, X., ...
Sample 1
Attention Deficit/Hyperactivity Disorder. According to the 2016-2017 National Survey of Children’s Health, about 6 million children of 3 to 17 years old are currently diagnosed with either Attention Deficit Disorder (ADD) or ADHD (18). Based on a longitudinal study following adolescents to young adulthood, being diagnosed with ADHD was associated with smoking tobacco or marijuana (49). Adolescents with ADHD were more likely to initiate cigarettes and e- cigarettes but not hookah (19,20,21,22,23). For cigars and SLTs, there was lack of literature on any associations with ADHD. As for marijuana, adolescents with ADHD smoked marijuana more frequently (21,22).
Sample 1
Attention Deficit/Hyperactivity Disorder. Cognitive or behavioral therapies for the treatment of these disorders are not covered.
Sample 1
Attention Deficit/Hyperactivity Disorder. (ADHD) Asthma
Sample 1
Attention Deficit/Hyperactivity Disorder. The Commission as of the date hereof has requested additional documents from Kaire.
Sample 1

Related to Attention Deficit/Hyperactivity Disorder

  • Change of Control Triggering Event (a) If a Change of Control Triggering Event occurs, unless the Company has exercised its option to redeem the Offered Securities, it shall be required to make an offer (a “Change of Control Offer”) to each Holder of the Offered Securities to repurchase, at the Holder’s election, all or any part (equal to $1,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Offered Securities on the terms set forth herein. In a Change of Control Offer, the Company shall be required to offer payment in cash equal to 101% of the aggregate principal amount of Offered Securities repurchased, plus accrued and unpaid interest, if any, on the Offered Securities repurchased to the date of repurchase (a “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event or, at the Company’s option, prior to any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, a notice shall be mailed to the Trustee and to the Holders of the Offered Securities describing in reasonable detail the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to repurchase such Offered Securities on the date specified in the notice, which date shall be no earlier than 30 days and no later than 60 days from the date such notice is mailed (a “Change of Control Payment Date”). The notice shall, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date.

  • Protected Activity Not Prohibited Nothing in this Agreement or in any other agreement between you and the Company, as applicable, will in any way limit or prohibit you from engaging for a lawful purpose in any Protected Activity. For purposes of this Agreement, “Protected Activity” means filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any state, federal, or local governmental agency or commission, including the U.S. Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (the “Government Agencies”). You understand that in connection with such Protected Activity, you are permitted to disclose documents or other information as permitted by law, and without giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, you agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information under the Confidentiality Agreement to any parties other than the Government Agencies. You further understand that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications. Any language in the Confidentiality Agreement regarding your right to engage in Protected Activity that conflicts with, or is contrary to, this paragraph is superseded by this Agreement. In addition, pursuant to the Defend Trade Secrets Act of 2016, you are notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!